Bentham Science Logo

Current Drug Targets

Volume 20, 16 Issues, 2019
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access

Ranking and Category

  • 131st of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print

Manuscript Transfer Facility

If the author’s manuscript is assessed as inappropriate to be published in his/her preferred journal, our editorial team may help the author in transferring the submission to a more appropriate Bentham Journal, through Bentham’s Manuscript Transfer Facility.

Transfer of Submission

Transfer of submission with Bentham’s Manuscript Transfer Facility is very simple.

Step 1.

The Author receives the transfer proposal by email - the transfer process is initiated by an affirmative response from the author to our transfer proposal.

Step 2.

The Authors’ manuscript is transferred to a suitable journal for initial editorial scrutiny.

Step 3.

The Author then receives an editorial decision from the journal.

Selection of another Journal

The Author is free to choose to submit the manuscript to a new journal by declining our transfer offer.

Our aim is to facilitate and develop rapid, effective and truly innovative solutions to facilitate our valued authors by enabling more options and better services to improve the publication process.


Editor-in-Chief

Francis J. Castellino
(14643 citations)
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
USA

View Full Editorial Board

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.
Track Your Manuscript:


Scopus CiteScore Metrics: 1.91

Related Journals

Related eBooks

eBooks Catalog